Roger Boissonneault

Title: The Innovative Contributions of Roger Boissonneault

Introduction

Roger Boissonneault is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug delivery. His work focuses on improving the efficacy and reliability of medication delivery systems.

Latest Patents

Roger Boissonneault holds a patent for a mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability. This innovative composition is designed to deliver mesalamine to the colon with improved consistency. Each dosage element contains mesalamine and an enteric coating that varies, allowing for different release points of the drug within the gastrointestinal tract. Specifically, one dosage element releases approximately 30% to 60% of the total mesalamine after 60 minutes at a pH of about 6.6, while another releases about 40% to 70% at a pH of about 7.2.

Career Highlights

Roger Boissonneault is associated with Allergan Pharmaceuticals International Limited, where he applies his expertise in pharmaceutical innovation. His work has contributed to advancements in drug formulations that aim to improve patient outcomes.

Collaborations

Throughout his career, Roger has collaborated with notable colleagues, including Ryan Gerald Loughlin and Stephen McCullagh. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Roger Boissonneault's contributions to pharmaceutical innovation, particularly in mesalamine delivery systems, highlight his commitment to improving healthcare solutions. His work exemplifies the importance of innovation in the pharmaceutical industry.